The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(benzo[d][1,3]dioxol-5-yl)-1H-benzo[d]imidazol-5-yl)-2-chlorobenzamide ID: ALA215363
PubChem CID: 44416710
Max Phase: Preclinical
Molecular Formula: C21H14ClN3O3
Molecular Weight: 391.81
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc2[nH]c(-c3ccc4c(c3)OCO4)nc2c1)c1ccccc1Cl
Standard InChI: InChI=1S/C21H14ClN3O3/c22-15-4-2-1-3-14(15)21(26)23-13-6-7-16-17(10-13)25-20(24-16)12-5-8-18-19(9-12)28-11-27-18/h1-10H,11H2,(H,23,26)(H,24,25)
Standard InChI Key: PJVQVFHLQKKXOY-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
-5.3393 -0.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3405 -1.2649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6256 -1.6778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9091 -1.2645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9120 -0.4338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6274 -0.0247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1939 -1.6758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1926 -2.5009 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4801 -1.2622 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7649 -1.6736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7683 -2.4971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0540 -2.9084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0580 -1.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4410 -1.4050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3430 -1.6654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3365 -2.4923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4525 -2.7402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9310 -2.0658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7559 -2.0571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6258 -2.5029 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.1711 -2.7681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9954 -2.7598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1540 -1.3398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9769 -1.3280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4033 -2.0378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2103 -1.8516 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2825 -1.0267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5202 -0.7030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13 10 2 0
15 16 2 0
1 2 2 0
4 7 1 0
3 4 2 0
7 8 2 0
14 15 1 0
16 17 1 0
17 18 1 0
18 14 2 0
7 9 1 0
18 19 1 0
4 5 1 0
3 20 1 0
9 10 1 0
19 21 2 0
2 3 1 0
21 22 1 0
22 25 2 0
10 11 1 0
24 23 2 0
23 19 1 0
24 25 1 0
5 6 2 0
11 12 2 0
12 16 1 0
6 1 1 0
15 13 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 391.81Molecular Weight (Monoisotopic): 391.0724AlogP: 4.86#Rotatable Bonds: 3Polar Surface Area: 76.24Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.53CX Basic pKa: 5.12CX LogP: 4.60CX LogD: 4.60Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -1.50
References 1. Wolkenberg SE, Zhao Z, Kapitskaya M, Webber AL, Petrukhin K, Tang YS, Dean DC, Hartman GD, Lindsley CW.. (2006) Identification of potent agonists of photoreceptor-specific nuclear receptor (NR2E3) and preparation of a radioligand., 16 (19): [PMID:16879962 ] [10.1016/j.bmcl.2006.07.056 ]